{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:21:47Z","timestamp":1792513307563,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.fertnstert.2021.01.023","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T22:32:27Z","timestamp":1615501947000},"page":"189-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Ulipristal acetate compared with leuprorelin acetate for Japanese women with symptomatic uterine fibroids: a phase III randomized controlled trial"],"prefix":"10.1016","volume":"116","author":[{"given":"Yutaka","family":"Osuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8964-3368","authenticated-orcid":false,"given":"Yasuaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2021.01.023_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0037-1607264","article-title":"Uterine fibroids: burden and unmet medical need","volume":"35","author":"Al-Hendy","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/jwh.2018.7076","article-title":"Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women","volume":"27","author":"Marsh","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejogrb.2016.02.026","article-title":"Myoma-associated pain frequency and intensity: a retrospective evaluation of 1548 myoma patients","volume":"199","author":"David","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/IJWH.S133212","article-title":"Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis","volume":"9","author":"Fuldeore","year":"2017","journal-title":"Int J Women\u2019s Health"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib6","first-page":"1493","article-title":"Committee report June 2015","volume":"67","year":"2015","journal-title":"Acta Obstet Gynaecol Jpn"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/jwh.2013.4334","article-title":"The burden of uterine fibroids for African-American women: results of a national survey","volume":"22","author":"Stewart","year":"2013","journal-title":"J Women\u2019s Health"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0033-1348896","article-title":"Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma","volume":"31","author":"Catherino","year":"2013","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib10","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0029-7844(97)00534-6","article-title":"Variation in the incidence of uterine leiomyoma among premenopausal women by age and race","volume":"90","author":"Marshall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/AOG.0b013e318197bbaf","article-title":"Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study","volume":"113","author":"Laughlin","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ajog.2010.02.039","article-title":"Racial and ethnic disparities in benign gynecologic conditions and associated surgeries","volume":"202","author":"Jacoby","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1507\/endocrj1954.37.907","article-title":"Calcium metabolism in premenopausal women treated by a Gn-RH agonist for uterine myoma","volume":"37","author":"Ito","year":"1990","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2302\/kjm.44.124","article-title":"Long-term gonadotropin-releasing hormone agonist therapy: the evolving issue of steroidal \"add-back\" paradigms","volume":"44","author":"Adashi","year":"1995","journal-title":"Keio J Med"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib16","article-title":"Selective progesterone receptor modulators for the medical treatment of uterine fibroids with a focus on ulipristal acetate","volume":"2018","author":"Rabe","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib19","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.fertnstert.2015.09.032","article-title":"Long-term medical management of uterine fibroids with ulipristal acetate","volume":"105","author":"Donnez","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/AOG.0000000000002462","article-title":"Ulipristal acetate for treatment of symptomatic uterine leiomyomas: a randomized controlled trial","volume":"131","author":"Simon","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/AOG.0000000000002942","article-title":"Ulipristal acetate for treatment of uterine leiomyomas: a randomized controlled trial","volume":"132","author":"Liu","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.fertnstert.2016.06.012","article-title":"Role of ethnicity in treating uterine fibroids with ulipristal acetate","volume":"106","author":"Murji","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/rmb2.12304","article-title":"Ulipristal acetate for Japanese women with symptomatic uterine fibroids: a double-blind, randomized, phase II dose-finding study","volume":"19","author":"Irahara","year":"2019","journal-title":"Reprod Med Biol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib25","first-page":"734","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib26","first-page":"290","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1507\/endocrj.52.131","article-title":"GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects","volume":"52","author":"Murase","year":"2005","journal-title":"Endocr J"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib28","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2006-2816","article-title":"Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial","volume":"92","author":"Chabbert-Buffet","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/AOG.0000000000003141","article-title":"Oral gonadotropin-releasing hormone antagonist relugolix compared with leuprorelin injections for uterine leiomyomas: a randomized controlled trial","volume":"133","author":"Osuga","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.01.023_bib31","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/14740338.2018.1550070","article-title":"Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program","volume":"17","author":"Donnez","year":"2018","journal-title":"Expert Opin Drug Saf"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:15:59Z","timestamp":1762150559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028221000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0015028221000443"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.01.023","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ulipristal acetate compared with leuprorelin acetate for Japanese women with symptomatic uterine fibroids: a phase III randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}